Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,748.00    -12.00 (-0.32%)
Bid:
3,748.00
Ask:
3,752.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Director/PDMR Shareholding

2 Apr 2020 15:34

RNS Number : 6355I
4imprint Group PLC
02 April 2020
 

 

2 April 2020

 

4imprint Group plc (the "Company")

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons.

 

 

The Company received notification on 2 April 2020 from each of Kevin Lyons-Tarr and David Seekings, Directors of the Company, that on 2 April 2020 they had received, respectively, 4,121 and 2,747 Ordinary Shares of 38 6/13 pence each in the Company. These shares resulted from the vesting of nil cost conditional share awards granted on 30 March 2017, pursuant to the 4imprint Group plc 2015 Incentive Plan ("Plan").

 

These transactions, in accordance with the rules of the Plan, represent the deferred release, after a 'lock-in' period of three years, of share awards relating to performance in the 2016 financial year. There is no cash outflow from the Company resulting from these transactions, other than a minimal amount of US Social Security.

 

Both Kevin Lyons-Tarr and David Seekings intend to retain all of their vested shares. They have, therefore, each paid the personal tax arising immediately on the vesting of the shares, as opposed to selling any element of their shares in order to satisfy their tax obligations.

 

As a result of the above, the total interests respectively of Kevin Lyons-Tarr and David Seekings in the Company are 262,301 and 184,074 shares, representing 0.93% and 0.66% of the Company's issued share capital.

 

The Company has also received notification from Kevin Lyons-Tarr and David Seekings that they have declined the award of nil cost conditional share awards made on 30 March 2020, relating to performance in the 2019 financial year.

 

 

 

Emma Taylor

Company Secretary

4imprint Group plc

Tel: + 44 (0) 20 3709 9680

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Kevin Lyons-Tarr

2. David Seekings

2.

Reason for the notification

a.

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

b.

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

4imprint Group plc

b.

LEI

213800G95T751RN2CT94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 38 6/13 pence

 

GB0006640972

b.

Nature of the transaction

Vesting of Conditional Share Awards pursuant to the 4imprint 2015 Incentive Plan

c.

Price(s) and volume(s)

 

 

 

 Price(s) 

Volume(s)

1.

Nil

4,121

2.

Nil

2,747

 

d

Aggregated information

 

· Aggregated volume

· Price

 

 

 Price(s) 

Volume(s)

1.

Nil

4,121

2.

Nil

2,747

 

 

e.

Date of the transaction

2 April 2020

f.

Place of the transaction

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVSSLIFIII
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.